These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1635136)

  • 1. Urodynamic dysfunction in walking myelodysplastic children.
    Dator DP; Hatchett L; Dyro FM; Shefner JM; Bauer SB
    J Urol; 1992 Aug; 148(2 Pt 1):362-5. PubMed ID: 1635136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal outcome in myelodysplastic patients with untreated, risky vesico-sphincter dysfunction].
    Romero Maroto J; Perales Cabanas L; Rodríguez Luna JM; Fernández Fernández A; Escudero Barrilero A
    Actas Urol Esp; 1989; 13(5):357-62. PubMed ID: 2596354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urological consequences of incomplete cord lesions in patients with myelomeningocele.
    Keshtgar AS; Rickwood AM
    Br J Urol; 1998 Aug; 82(2):258-60. PubMed ID: 9722763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urologic problems in anorectal malformations. Part 2: functional urologic sequelae.
    Boemers TM; de Jong TP; van Gool JD; Bax KM
    J Pediatr Surg; 1996 May; 31(5):634-7. PubMed ID: 8861470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder functional changes resulting from lipomyelomeningocele repair.
    Atala A; Bauer SB; Dyro FM; Shefner J; Shillito J; Sathi S; Scott RM
    J Urol; 1992 Aug; 148(2 Pt 2):592-4. PubMed ID: 1640529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration.
    Kasabian NG; Bauer SB; Dyro FM; Colodny AH; Mandell J; Retik AB
    Am J Dis Child; 1992 Jul; 146(7):840-3. PubMed ID: 1496955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An objective score to predict upper tract deterioration in myelodysplasia.
    Galloway NT; Mekras JA; Helms M; Webster GD
    J Urol; 1991 Mar; 145(3):535-7. PubMed ID: 1997704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup.
    Hopps CV; Kropp KA
    J Urol; 2003 Jan; 169(1):305-8. PubMed ID: 12478177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodynamic correlates of resolution of reflux in meningomyelocele patients.
    Agarwal SK; McLorie GA; Grewal D; Joyner BD; Bägli DJ; Khoury AE
    J Urol; 1997 Aug; 158(2):580-2. PubMed ID: 9224367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urologic monitoring of children with meningomyelocele].
    Treiber U; Beckert R; Müller M; Thon WF
    Klin Padiatr; 1987; 199(6):440-4. PubMed ID: 3431022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurosurgical implications of continuous neurourological surveillance of children with myelodysplasia.
    Lais A; Kasabian NG; Dyro FM; Scott RM; Kelly MD; Bauer SB
    J Urol; 1993 Dec; 150(6):1879-83. PubMed ID: 8230524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urodynamic evaluation of boy with myelodysplasia and incontinence.
    Bauer SB; Labib KB; Dieppa RA; Retik AB
    Urology; 1977 Oct; 10(4):354-62. PubMed ID: 919122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurovesical dysfunction in children after treating pelvic neoplasms.
    Mosiello G; Gatti C; De Gennaro M; Capitanucci ML; Silveri M; Inserra A; Milano GM; De Laurentis C; Boglino C
    BJU Int; 2003 Aug; 92(3):289-92. PubMed ID: 12887486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesico-ureteral reflux in children with spina bifida and detrusor-sphincter dyssynergia.
    van Gool JD
    Contrib Nephrol; 1984; 39():221-37. PubMed ID: 6744873
    [No Abstract]   [Full Text] [Related]  

  • 16. Urological outcome after myelomeningocele: 20 years of follow-up.
    Thorup J; Biering-Sorensen F; Cortes D
    BJU Int; 2011 Mar; 107(6):994-9. PubMed ID: 20860652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urodynamic examination of the lower urinary tract in children with normal and congenital neurogenic bladder.
    Thorup J
    Scand J Urol Nephrol Suppl; 1994; 158():1-59. PubMed ID: 7817158
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of toxin-A Botulinum for treating intractable bladder hyperactivity in children affected by neuropathic bladder secondary to myelomeningocele: an alternative to enterocystoplasty].
    Marte A; Vessella A; Cautiero P; Romano M; Borrelli M; Noviello C; Del Gado R; Parmeggiani P
    Minerva Pediatr; 2005 Feb; 57(1):35-40. PubMed ID: 15791200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does surgical release of secondary spinal cord tethering improve the prognosis of neurogenic bladder in children with myelomeningocele?
    Tarcan T; Onol FF; Ilker Y; Simsek F; Ozek M
    J Urol; 2006 Oct; 176(4 Pt 1):1601-6; discussion 1606. PubMed ID: 16952698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of spina bifida with vesicoureteral reflux (VUR) successfully treated by early management].
    Yamamoto M; Momose H; Okamura K; Shiomi T; Yamada K
    Hinyokika Kiyo; 1987 Feb; 33(2):237-41. PubMed ID: 3591588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.